key: cord-0916283-yftwt72e
authors: Zhou, Yue; Chi, Jingwei; Lv, Wenshan; Wang, Yangang
title: Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 (COVID‐19)
date: 2020-06-26
journal: Diabetes Metab Res Rev
DOI: 10.1002/dmrr.3377
sha: f2e13c1d76e66c8618408b239a984354684ec980
doc_id: 916283
cord_uid: yftwt72e

The outbreak of the coronavirus disease 2019 (Covid‐19) has become an evolving worldwide health crisis. With the rising prevalence of obesity and diabetes has come an increasing awareness of their impacts on infectious diseases, including increased risk for various infections, post‐infection complications and mortality from critical infections. Although epidemiological and clinical characteristics of Covid‐19 have been constantly reported, no article has systematically illustrated the role of obesity and diabetes in Covid‐19, or how Covid‐19 affects obesity and diabetes, or special treatment in these at‐risk populations. Here, we present a synthesis of the recent advances in our understanding of the relationships between obesity, diabetes and Covid‐19 along with the underlying mechanisms, and provide special treatment guidance for these at‐risk populations.

The outbreak of the coronavirus disease 2019 (Covid- 19) has become a public health emergency of international concern 1 , which caused by a novel enveloped RNA beta-coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 2 . The manifestations of Covid-19 pneumonia run the spectrum from asymptomatic disease to severe acute respiratory infection [3] [4] [5] [6] . The recognized human-tohuman transmission of Covid-19 significantly increases the risk of much wider spread of the disease [7] [8] [9] .

As of June 3, 2020, 6 287 771 confirmed Covid-19 cases and 379 941 deaths were reported globally, with most of the cases being reported from United Stats, Europe and Eastern Mediterranean 10 . At present, the number of Covid-19 cases is still increasing around the world, and there are increasing global concerns about this outbreak 11 .

Obesity and diabetes are increasingly worldwide health concerns, and have been regarded as critical risk factors for various infections, post-infection complications and mortality from severe infections 12 .

Both of obesity and diabetes have been shown deleterious effects on host immunity, which primarily increased the risk for infectious susceptibility and severity 12, 13 . Having diabetes generally worsens infection prognosis, with these patients showing increased morbidity and mortality from sepsis compared to the general population 14 . Obesity has been shown to affect lung function in multiple ways, related to mechanical and inflammatory aspect, making the obese more likely to suffer with respiratory symptoms and progress to respiratory failure 15 .

In the Covid-19 epidemics, researchers found the comorbidities were present in nearly half of inpatients with Covid-19, with hypertension being the most common comorbidity, followed by diabetes and coronary heart diseases (CVDs) [4] [5] [6] 16, 17 . Moreover, the percentages of diabetes and CVDs are much higher among the fatality cases than among the confirmed Cvoid-19 cases 3, 18 . At present, although This article is protected by copyright. All rights reserved.

of SARS-CoV-2 infection, with the absence of classical worrisome signs and clinical symptoms, which may result in a life-threatening delay in providing the needed care. On the other hand, there was also an argument that after adjusting for age, race, country, cardiovascular medication use and other coexisting conditions, diabetes mellitus was not an independent predictor of in-hospital death 28 , which should be considered with caution due to the absence of evidence from randomized controlled trials and the concerns about the quality of the database information in that study. Several factors may be responsible for the increased severity of Covid-19 in diabetes (Table 1 ).

Individuals with diabetes are generally affected by a low-grade chronic inflammation, which might facilitate the cytokine storms, contributing to the severe outcomes of Covid-19 and the eventual death 29,30 .

Guo et al. 24 published the first study of biochemical features of Covid-19 patients with diabetes, which indicated that the absolute count of lymphocytes in diabetic patients is significant lower than those without diabetes, while the count of neutrophils is remarkably higher. Similarly, subsequent retrospective studies 25-27 comparing the clinical features between Covid-19 patients with and without diabetes also showed a higher neutrophil-to-lymphocyte ratio (NLR), high-sensitivity C reaction protein, and procalcitonin. The levels of some inflammation-related biomarkers were also increased in diabetic patients, while interleukin (IL)-6 among the different markers (fibrinogen, C-reactive protein, D-dimer) were found to be more elevated 25,31 . The higher NLR and lymphocyte-to-C-reactive protein ratio, as well as the elevated inflammation-related biomarkers, were identified as independent risk factors for severe outcomes in Covid-19 patients 31,32 . Additionally, recent preliminary observations have shown that tocilizumab, a monoclonal antibody against the IL-6 receptor, may help the treatment of Covid-19. It is actually being used off-label in some Italian centers and is currently being tested in a randomized controlled trial 33 . Besides, a significant increase in serum ferritin also indicates the activation of the monocyte-macrophage system, which is a crucial part of inflammatory storm 26 . Therefore, these results indicate that patients with diabetes are susceptible to form an inflammatory storm, which eventually lead to rapid deterioration of This article is protected by copyright. All rights reserved.

Besides the higher NLR, recent studies showed the number of total T cells, and CD4+ and CD8+ T cell subsets were significantly reduced and functionally exhausted in Covid-19 patients, especially among severe cases 34,35 , suggesting a role for dysregulated immune responses in Covid-19 pathogenesis.

Actually, in diabetic individuals, persistent hyperglycemia could lead to a series of abnormal metabolic changes 14, 36 , which together increase the production of superoxide and activation of inflammatory pathways, promoting the dysfunction of immune system 37 .

Nonspecific and fast-acting innate immune defenses, which provide initial host response to the SARS-CoV-2 invasion, are impaired in multiple ways in diabetes. In particular, neutrophils exhibit defects in almost all functions, including migration to inflammatory sites, release of lytic proteases, phagocytosis, production of reactive oxygen species (ROS), and apoptosis 38 . A study evaluating cytokines from neutrophils in subjects with type 2 diabetes (T2D) found excessive release of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-8 in both the basal and stimulated state, which increased the susceptibility to invasive pathogens 39 . In diabetic individuals, there is an increased ratio of M1 pro-inflammatory macrophages releasing inflammatory mediators 40 , contributing to the increased local and systemic inflammation. The phenotypes and activity of natural killer (NK) cells are also altered in diabetes 41 , with significant decreases in NK receptors recognizing virus and activating receptors on NK and CK8+ T lymphocytes. Hyperglycemia and hyperinsulinemia could also induce a proinflammatory cytokine profile in dendritic cells (DC)s, together with the stimulation of AGE products, leading to their maturation 42 . However, the role of the maturation and activation of DCs in immune responses is still not well understood.

Obesity and diabetes also weaken the control and clearance of pathogens with the dysfunction of adaptive immune system. Generally, the proper balance between pro-inflammatory (Th17 or Th1) and anti-inflammatory [Th2 or regulatory T cells (Tregs)] subsets of CD4+ effector T cells is vital to maintain host immunity and control inflammatory damage 43 . In T2D, T cells are over-activated and the inflammatory processes are promoted 44, 45 . In the adipose tissue of diabetic subjects, anti-inflammatory This article is protected by copyright. All rights reserved .   macrophages are transformed into pro-inflammatory macrophages, while Tregs transformed into helper   Th1 and Th17 CD4+ T cells 46, 47 . In particular, the pro-inflammatory Th1, which triggers cell-mediated immunity and phagocyte-dependent inflammation, was upregulated 48 . Th17, another pro-inflammatory CD4+ T cell subtype secreting IL-17 and stimulating TNF-α production, was increased 49 . Treg cells, which suppress Th1, Th2, and Th17 response to improve insulin resistance (IR) and inhibit the inflammatory response, were reduced in diabetes 50 . Additionally, insulin signaling in T cells could cause increased glucose uptake, amino acid transport, lipid metabolism and protein synthesis, which promotes T cell activation and responsiveness 51 . Thus, in addition to the amounts disproportion, the presence of insulin resistance or deficiency could suppress the insulin signaling, leading to abnormal T cell response to pathogens. In addition to CD4+ T cells, CD8+ T cells are also essential for the adaptive immune response against infections, by secreting cytokines such as IFN-γ and TNF-α, as well as expressing proinflammatory cytokines such as IL-17 52 . It has been showed that diet-induced obese subjects have higher percentages of CD8+ T cells 53 , however, the proportion of CD8+ T cells would decrease after 120 min of glucose loading 54 . Besides, pathogenic CD8+ T cell subsets which control hepatic IR and gluconeogenesis were found to accumulate in the liver 55 , suggesting that the increased CD8+ T cells and subsequent IFN-γ production promote IR and inflammation state 56 . Therefore, the imbalance of CD4 + /CD8 + T cells and CD4+T cells subsets, together with the impaired T-cell response in diabetes make the adaptive immune abnormal.

Abundant evidence shows that diabetes is associated with physiological and structural abnormalities in lung tissues and attenuation in lung function 57, 58 , reminding that diabetes could worsen the lung injury besides the immunodeficiency. Diabetic individuals tend to exhibit lower forced vital capacity (FVC) and forced expiratory volume in one second (FEV1), and lower diffusion capacity (DLCO) versus nondiabetic individuals 59 . Specially, oxidative stress result from sustained hyperglycemia has been postulated to be a major contributor in diabetic lung injury 60 , which damaged the respiratory system due to the pulmonary interstitial injury mainly caused by microangiopathy 61 . To date, the definitive direction This article is protected by copyright. All rights reserved.

or the exact pathophysiological mechanism to explain the interactions between diabetes and lung function has not been well understood.

Increasing evidence suggests that Covid-19 uses human angiotensin-converting enzyme 2 (ACE2) as a receptor for cellular entry, which potentially facilitates the person-to-person transmission 62 . Moreover, the SARS-CoV-2 binds ACE2 with approximately 10-to 20-fold higher affinity than ACE2 binding to SARS-CoV 63 , making ACE2 a special target for SARS-CoV-2 invasion. ACE2, which is a central member of the renin angiotensin system (RAS) family that degrades Ang II into Ang 1-7, has been implicated in hypertension, diabetes, and CVDs 64 . ACE2 expression has been found in multiple organs including kidneys, hearts, testis, lungs, pancreas, bladder, stomach, ileum, and liver 65, 66 , which may account for the multiple organ failure seen in some Covid-19 patients. Interestingly, experts found that diabetes significantly up-regulated the expression of ACE2 in the circulation, which may be ascribed to a compensatory mechanism of RAS, and insulin administration significantly decreased the ACE2 expression [67] [68] [69] . The levels of urinary ACE2 and enzymatic activity were also found increase in both type 1 70 and type 2 71 diabetic patients, and the urinary ACE2/Creatinine ratios positively correlated with blood glucose levels 72 . Seen in this light, the diabetes-induced overexpression of ACE2, as a functional receptor for SARS-CoV-2 invasion, might increase the susceptibility to Covid-19. However, there is also experimental evidence for downregulation of ACE2 in kidney tissue in diabetes 73 , suggesting that the expressions of ACE2 in diabetes vary depending on the studied tissues. With the evidence that increased ACE2 and consequently angiotensin 1-7 have vasodilatory and antifibrotic effects which showed protective effects against lung injury 74 , some researchers thus considered that the reduced ACE2 may predispose to more severe lung injury 75 . Besides ACE2, diabetes is also associated with increased plasminogen levels which has been postulated to increase the virulence and infectivity of SARS-CoV-2 by cleaving its spike proteins 76 . Increased virulence and infectivity of SARS-CoV-2 in diabetes may also due to an increase in furin, which is a type-1 membranebound protease involved in the entry of coronaviruses into the cell 77 . Recently, Fadini et al. 78 have conducted a meta-analysis regarding the This article is protected by copyright. All rights reserved.

impact of diabetes among subjects with Covid-19, which showed no increased susceptibility, but only higher increase to worsen progression of Covid-19 in patients with diabetes compared with those without diabetes. To date, there is no conclusive evidence supporting that diabetes increases the susceptibility to Covid-19 infection, therefore, additional studies are needed to investigate this possibility.

In addition to the detrimental effects, chronic comorbidities associated with diabetes like obesity, hypertension, coronary artery disease and chronic kidney disease, could further worsen the prognosis of Covid-19 3-6,16-19 .

Viral infection might in turn induce glucose dysregulation in preexisting diabetes, or even cause newonset diabetes in those without a history of diabetes (Table 2) , which worked as an amplification loop and formed a vicious circle.

Recent clinical researches showed that the insulin dose increased and blood glucose became difficult to control after diabetic patients were infected with SARS-CoV-2 24,79,80 . Particularly, Guo et al. 24 observed that 37.5% of the diabetic patients took oral drugs before and started insulin therapy after admission, and 29.2% of the patients took insulin before and increased the dose of insulin after admission.

Zhou et al. 79 retrospectively analyzed 881 capillary blood glucose (BG) tests in patients with both diabetes and Covid-19, and found that 56.6% of the tests showed abnormal BG levels, 69.0% of the patients had non-ideal BG levels, and 10.3% of the patients suffered at least one episode of hypoglycemia.

In general, during the illness and social isolation, an increasing number of diabetic patients are cancelling their routine visits to diabetes clinics. This development along with the enhanced stress associated with disease and isolation, reduced physical activity, irregular diets, and the disease-associated gastrointestinal symptoms, provides a fertile ground for worsening glycemic control. Under the stress state of infection and mood instability, elevated secretion of hyperglycemic hormones such as catecholamines or glucocorticoids might further increase the BG instability. Additionally, despite that the corticosteroid use is not among the first line therapy in Covid-19 treatment 81 , we still should admit that the use of This article is protected by copyright. All rights reserved.

glucocorticoids will induce sharp rises in blood glucose.

On the side, some viruses have been shown diabetogenic 82 . Jali et al. 83 reported two subjects presenting with acute insulin-dependent diabetes for a brief and transient period after being infected with chicken pox. SARS was also found to cause secondary hyperglycaemia in patients who had no history of diabetes and had not used any glucocorticoids during the course of the disease 84 . Interestingly, experts found the immunostaining of ACE2 is strong in islets 85 , and indicated that SARS-CoV might enter islets using ACE2 as its receptor and cause acute diabetes by damaging islets. Similarly, secondary hyperglycaemia was also found in patients without a history of diabetes infected with SARS-CoV-2 80 . Pancreatic injury, determined by assessment of plasma levels of amylase and lipase, was observed in 17.3% patients with Covid-19 in China, and 66.7% patients also exhibited moderate increases in blood glucose 86, 87 . The emerging putative association of pancreatic injury and SARS-CoV-2 is consistent with expression of ACE2 in the exocrine and endocrine pancreas 88 . Thus, we assume that SARS-CoV-2 may bind to ACE2 in vital organs including liver and pancreas, with a potential role in the development of IR and impaired insulin secretion, causing acute diabetes or worsen diabetes prognosis. However, to date, no studies have determined whether Covid-19 induces new-onset diabetes or which signaling pathways it adopts, thus additional studies are needed to investigate this possibility.

Under the Covid-19 epidemic, all of the life styles, treatment strategies, and therapeutic effects of diabetic patients could be severely impaired, increasing the difficulty of the blood glucose management. An individualized strategy for blood glucose management should be developed according to the clinical typing of Covid-19, condition of diabetes and its complications. All of the psychological care, healthy lifestyle, intensive blood glucose monitoring, and reasonable medicine treatment are necessary for diabetes care in patients with Covid-19 89 . Specially, in regard to the choices of drug uses in diabetic patients, there are a few points to note.

First comes the confounding role of ACE inhibitors (ACEis) and angiotensin II type-I receptor blockers (ARBs), which are widely used in diabetic individuals. There is concern that the pharmacologic This article is protected by copyright. All rights reserved. RAS inhibition will indirectly increase ACE2 expression 90 

Interest in the interactions between obesity and infection has been prompted by the H1N1 pandemic in 2009 [105] [106] [107] [108] . Published data indicated that obese individuals were more susceptible to respiratory virus infection, to a greater severity of illness and adverse endpoints after infection including higher rates of hospitalization, admission to ICU, and death [105] [106] [107] [108] [109] . In this Covid-19 epidemic, a greater rates of obesity and severe obesity among Covid-19 patients, relative to historical non-Covid-19 controls, has also been reported. In the case series including 5700 patients hospitalized with Covid-19 in the New York city, a higher prevalence of obesity (41.7%) compared to diabetes (33.8%) was found 110 , suggesting obesity as an underappreciated risk factor for Covid-19. The risk associated with obesity might be particularly relevant in the USA because the prevalence of obesity is approximately 40%, versus a prevalence of 6.2%

in China, 20% in Italy, and 24% in Spain 111 . Report from the USA also showed that, among Covid-19 patients younger than 60 years, those with a BMI 30-35 kg/m 2 and over 35 kg/m 2 were 1.8 and 3.6 times more likely to be admitted to ICU, respectively, compared to those with a BMI < 30 kg/m 2 This article is protected by copyright. All rights reserved.

Obesity is an inflammatory state associated with chronic activation of the immune system, which negatively affects immune functions and host defense mechanisms, resulting in high rates of infectious complications and vaccine failure 13 . Besides, the altered pulmonary physiology, increased receptors for virus invasion, increased viral diversity and titers, and prolonged viral shed, together make the SARS-CoV-2 infection in obesity complicated.

Chronic inflammation is a common feature of obesity mainly resulting from metabolic tissue stress induced by weight gain and AT dysfunction 116, 117 . In obesity, the hypertrophic adipocytes are more prone to activating endoplasmic reticulum and mitochondrial stress responses, which promote the activation of a chronic, pro-inflammatory state within AT 116, 118 . Persistent stress and inflammation within AT further lead to adipocyte apoptosis and the release of chemotactic mediators, leading to inflammatory leukocyte infiltration 119 and increased secretion of pro-inflammatory cytokines 120 , which further perpetuate the hypertrophy-induced dysfunctional state. Moreover, AT also secretes several pro-inflammatory cytokines, chemokines and adipokines releasing into the circulation, contributing to a systemic low-grade chronic inflammation 121 . Additionally, viruses could also express tropism for different tissues and cell types including ATs and adipocytes 122, 123 . Considering the fact that SARS-CoV-2 uses an ACE2-dependent mechanism of cellular entry, which is also expressed by fat including ectopic reservoirs 124 , the SARS-CoV-2 might as well have a tropism for the AT, which further contributes to the intrapulmonary and systemic inflammation 125 . Subsequently, the inflammation-recruited immune cells differentiate into inflammatory subsets and secrete additional pro-inflammatory molecules, contributing to the maintenance of the local and systemic chronic inflammation state 126 . The obesity-related chronic inflammation could inhibit macrophage activation and migration, impair the generation of neutralizing antibody and memory T cells, and decrease the activation of effector cells of the immune system, which suppressed immune functions and host defenses [127] [128] [129] [130] . Given this, we hold the opinion that the local and systemic chronic inflammation in obesity contributes to the immune dysfunction, which increased the This article is protected by copyright. All rights reserved. risk for Covid-19.

By the secretion of adipokines, AT mediates the interactions between immune system and metabolic cells, suggesting that obesity may compromise the immune surveillance 131 . With the presence of obesity, complex interactions take place between immune and metabolic cells. Specially, the adipocyte-derived leptin could regulate the hematopoiesis of bone marrow, generation and development of T cells in the thymus, and determine T cell subsets in lymph nodes [132] [133] [134] . Leptin signaling is also important for nearly all parts of the innate immune response, including the expression of antiviral cytokines (IFN-α/β), proinflammatory IL-6, and TNF-α, as well as the activation and stimulation of monocytes, DCs and macrophages 135 . In obese subjects, the relative deficiency in leptin and/or the leptin resistance of immune cells 136 , negatively affects the production and activation of T cells and impairs the immune responses 134, 137 . Adiponectin, another key adipokine intimately associated with obese status, has in addition been shown to affect immunity. Whereas leptin plays a more significant role in preparing and initiating immune responses, adiponectin is essential for inflammatory resolution, with both antiinflammatory and insulin-sensitizing properties 138 . Teoh et al. 139 showed that adiponectin-deficient mice had an 8-fold greater risk of sepsis-related mortality than wild-type models, and that the loss of adiponectin increased endothelial activation and inflammation. Therefore, the leptin resistance related to high leptin levels, together with the decreased adiponectin levels in obesity contribute to the heightened pro-inflammatory cytokine production as well as the poor responsiveness to infection stimuli.

Both T cell and B cell responses present reduced efficacy in the obese host, which increases the infection susceptibility and impairs the resolution of Covid-19. Increasing evidence described the deficiencies in activation and function of CD4+ and CD8+ T cells in obese hosts 45, 134, 140, 141 , with more IL-5 production and lower IFN-γ production. Particularly, obesity-related metabolic dysregulation has been regarded as the driver of poor effector T cell and helper T cell function, as well as impaired memory T cell responses in obesity, owning to the altered T cell metabolism 142 .

This article is protected by copyright. All rights reserved.

with increasing obesity status, while the remaining cells show increased differentiation that impaired their antiviral functionality and response to antigen presentation 143 . Karlsson et al. 144 also indicated that the failure to maintain CD8+ memory T cell responses in obesity impairs the vaccine efficacy and increase mortality following challenge influenza infection. Interestingly, Misumi et al. 145 observed that obesity increases memory T cell frequencies within ATs, leading to a unique form of viral pathogenesis involving memory T cell-dependent adipocyte destruction. On the side, increased visceral adiposity in obesity also attracts increased B cell amounts, contributing to systemic chronic inflammation through interactions with T cells 146 .

With the observation of a better respiratory function and reduced IL-6 secretion in complementdeficient models, experts have regarded the complement system as an important host mediator of SARS-CoV-induced disease 147 . Interestingly, excess fat has been shown associated with the hyperactivation of complement system 148 , potentially capable of inducing inflammatory sequelae ultimately developing a condition described as ''cytokine storm'' 29 . Additonally, eculizumab, an antibody with complement system modulatory activity, is now being studied in a clinical trial (ClinicalTrials.gov Identifier: NCT04288713) to assess its effect on the adverse outcomes associated with Covid-19.

Increasing evidence suggest that obesity could result in altered lung mechanics and physiology, including altered topographical distribution of ventilation, reduced lung volumes, decreased compliance, abnormal ventilation and perfusion distribution, and respiratory muscle inefficiency 15, 149, 150 . Specially, obese individuals allocate a disproportionately high percentage of total body oxygen consumption to respiratory work, resulting in a reduced functional residual capacity and expiratory volume 151 . These changes could further induce or aggravate the asthma or asthma-like symptoms such as dyspnea and wheeze 15 .

Subsequent ventilation-perfusion abnormality further decreases the ventilatory reserve, making the obese more prone to respiratory failure 151 . Furthermore, obesity is shown to be strongly and independently associated with a higher prevalence of pulmonary embolism 152 . Therefore, the presence of increased This article is protected by copyright. All rights reserved. airway resistance, impaired gas exchange, chronic inflammation of the respiratory tract, and increased risk of pulmonary embolism due to obesity may together affect the outcome of lung injury. This may increase the risk of acute respiratory failure or even multiple organ failure after Covid-19.

ACE2 is secreted by mature adipocytes and presented in the white and brown ATs 153 . In obese individuals, the adipocyte size increases and the white AT becomes hypertrophied due to macrophages infiltration with the increased secretion of pro-inflammatory cytokines 154 . Although current studies suggested that the levels of ACE2 expressed by adipocytes and adipose progenitor cells were similar between non-obese and obese subjects 155, 156 , obese subjects have more adiposes so as to increase the number of ACE2expressing cells, thus increasing the total amount of ACE2 67, 69 . Pinheiro et al. 156 further showed that, the obesity-related inflammation in the ATs leads to RAS up-regulation, which may contribute to the establishing metabolic disorders and increased susceptibility to infections. In contrast, the mild to moderate food restriction is associated with down-regulation of key RAS components 156 . As has been noted, SARS-CoV-2 uses ACE2 as its functional host-cell receptor to invade hosts 62 . Seen in this light, we assumed that the obese-induced overexpression of ACE2, as a functional receptor for SARS-CoV-2 invasion, may play a key role in the increased susceptibility to Covid-19, and the increased risk for progression to acute respiratory failure or even multiple organ failure.

Under the influenza virus infection, researchers observed that obesity is associated with increased disease severity, prolonged viral shed, elevated viral titers in exhaled breath, and increased viral diversity [157] [158] [159] .

Latest data suggested that, the obesogenic microenvironment, characterized by an impairment of the IFN response, permits the emergence of potentially pathogenic variants with increased replication ability and enhanced virulence, leading to a more diverse viral quasispecies 157 . Besides, obesity has been implicated in altering within-host viral evolution, together with the prolonged infections, delayed clearance and increased shedding, potentially promoting the viral transmission 160 .

This article is protected by copyright. All rights reserved.

In addition to the detrimental effects, obesity is a confirmed cause of diabetes and CVDs [161] [162] [163] , which were also considered as the risk factors for developing severe Covid-19-19 [3] [4] [5] [6] [16] [17] [18] [19] .

It should be mentioned that, in evaluating obesity as a risk factor for poor outcomes associated with

Covid-19, age should be considered as a possible influential factor. Kass et al. 164 have examined the correlation between BMI and age in 265 Covid-19 patients admitted to ICU in the USA. Interestingly, they found a significant inverse correlation between age and BMI, in which younger patients admitted to hospital were more likely to be obese. This suggested that, in populations with a high prevalence of obesity, Covid-19 will affect younger populations more than previously reported. Therefore, public notification to younger adults, lowering the threshold for virus testing in obese subjects, and maintaining greater vigilance for this at-risk population should reduce the prevalence of severe Covid-19 disease 164 .

Previous researches have suggested that some virus play a role in the development of obesity and obesityrelated metabolic disorders. Adenovirus infection has been found associated with a sharp increase in body weight 123, 165, 166 . Possible mechanisms via which adenovirus infection induces obesity were summarized as follows: First, the virus-induced inflammation via increase in macrophage chemoattractant protein I (MCP-1) activated by NF-kB 122 . Second, a suppression of leptin production in the adipocytes leading to lipid accumulation by the decreased lipolysis, a downregulation of the adipocyte genes associated with lipid oxidation and fatty acid synthesis 167 . Third, the increase in glucose uptake by fat cells leading to an energy surplus in the cells glucose-dependent 123, 167 . Next, an up-regulation of adipogenesis due to enhanced adipocyte proliferation and differentiation 168 . Fifth, the modulation of hypothalamic monoamines leading to the reduction of corticosterone, which result in the reduction in metabolic activity 123 . On the side, acute respiratory infection has also been linked to the rapid development of transient insulin resistance, both in otherwise healthy euglycemic normal weight or overweight individuals 169 . Mice infected by the influenza virus have shown a metabolic imbalance resembling an insulin-resistant condition, with a metabolic shift toward an increase in glycolytic rate, a reduction in the mitochondrial pyruvate dehydrogenase complex activity, and a decrease in ATP This article is protected by copyright. All rights reserved. production 170 . Although the effects of Covid-19 on obesity have not yet been well described, the adenovirus and influenza experience should serve as a caution for the care of obesity. Additionally, islet inflammation mediated by islet macrophages has recently emerged as a key feature of obesity 171 . Under the Covid-19 infection, the chronic inflammatory processes tend to be more easily activated, which may contribute to the IR as well as β-cell dysfunction that characterizes T2D. Besides, with the cases of viral encephalitis, brain tissue edema, neuronal degeneration, and cerebrobasilar disease caused by SARS-CoV-2 attacking the nervous system increasingly reported, researchers recognized the destructive effects of SARS-CoV-2 on the nervous system 172, 173 . Whether SARS-CoV-2 has an impact on obesity involving the central as well as peripheral effects, is an interesting field to explore. Besides, the inability to go to work and exercise, emotional stress, and financial hardship will provide the perfect milieu for the obesity pandemic to rage even faster 174 . Possible impacts of Covid-19 infection on obesity were summarized in Table 2 .

Regarding the treatment of obese individuals under Covid-19 infection, there are a few points to note.

First, the efficacy of antivirals and vaccines could be reduced in obese patients 175 , which is not only result from the obese-induced chronic inflammation, but also the altered viral life cycle and increased viral diversity complementing the already weakened immune response 157, 175 . Whether the dosage of antivirals or vaccines should be adjusted in obese patients is a question worth thinking about. Specially, pharmacokinetics studies of oseltamivir showed that obese subjects clear the drug faster than non-obese subjects, but this increase in the clearance rate was non-obvious with potentially insignificant biological impact 176 . This suggests that dose adjustment for obese patients may be not necessary from a pharmacokinetic perspective, but the question remains concerning whether the dosage is appropriate to control viral replication 177 . Second, based on the tendency of prolonged shedding and spread of the virus in obese subjects 118, 159 , whether quarantine should be prolonged in obese subjects relative to non-obese subjects should be seriously and comprehensively considered 178 . Third, a balanced diet or a mild caloric restriction, instead of excessive dieting to lose weight, seems more important in obese patients with This article is protected by copyright. All rights reserved.

Covid-19 for the immunity considered 179 . Mild-to-moderate physical exercise is recommended, not only aiming at losing weight but also at quickly improving immune modulation 180, 181 . Fourth, different treatments for Covid-19 may have differential impacts on the obesity. In regarding to the antiviral agents, the use of hydroxychloroquine have been shown to reduce body weight, improve obesity-induced lipotoxicity and insulin resistance, though the peroxisome proliferator-activated receptor gamma pathway 182 . On the side, although there were decreases in total weight and BMI with the chloroquine treatment, researchers observed increases in total body fat in patients infected with hepatitis C virus 183 .

As the initially first-line agent in the management of Covid-19, lopinavir/ritonavir has been shown to induce lipodystrophy and metabolic syndrome, which leads to reduced weight, but increased plasma levels of lipids and insulin 184, 185 . Besides, it was reported that remdesivir has protective effects against high fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD), by regulating hepatocyte dyslipidemia and inflammation 186 . However, long-term antiviral treatment with azithromycin 187 , and both short-and long-term corticosteroids uses as the supporting treatment under severe circumstances 188,189 , have been shown to significantly increase body weight. Given the differential impacts of various treatments on obese patients, attention should be paid on stratification by BMI while evaluating safety and efficacy outcomes in the coming clinical trials.

The outbreak of the Covid-19 has become an evolving worldwide health crisis. With the rising prevalence of obesity and diabetes has come an increasing awareness of their impacts on infectious diseases. In diabetes, the chronic exposure to an abnormal metabolic environment may lead to persistent derangements in innate and adaptive immunity, aggravation of inflammatory storm, abnormalities in lung physiology and micrangium, and increase of virus infectivity and virulence, which may together increase the risk for Covid-19 poor prognosis. At present, whether diabetes increases the susceptibility to Covid-19 infection still lacks evidence. In addition to deleterious effects on host immunity, obesity is also associated with altered pulmonary mechanics and physiology, increased ACE2 expression, increased viral diversity and titers, and prolonged viral shed, which may further increase the susceptibility to Covid-This article is protected by copyright. All rights reserved. 19 

We thank the data provided by the authors of included in this review.

This study had no funding support.

The authors declare they have no competing interests. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved. 

Evidence References

Postulated 24-32

Higher NLR, hsCRP, and procalcitonin

Higher interleukin (IL)-6, ferritin, fibrinogen and D-dimer This article is protected by copyright. All rights reserved.

World Health Organization. Coronavirus disease (COVID-19) outbreak

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Characteristics of and Public Health Responses to the Coronavirus Disease

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

World Health Organization. Coronavirus disease (COVID-2019) situation reports

A novel coronavirus outbreak of global health concern. The Lancet

Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality

Association between obesity and vulnerability and serologic response to influenza vaccination in older adults

Sepsis in diabetes: A bad duo

The effect of obesity on lung function

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China

Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine

Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area

Diabetes and the Severity of Pandemic Influenza A (H1N1) Infection. Diabetes Care

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases

Biochemistry and molecular cell biology of diabetic complications

Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition

Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes

Human Chemokines: An Update

Human monocytes and macrophages undergo M1-type inflammatory polarization in response to high levels of glucose

Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes

Advanced Glycosylation End Products Might Promote Atherosclerosis Through Inducing the Immune Maturation of Dendritic Cells

Inflammatory Mechanisms in Obesity

Activated T Lymphocytes in Type 2 Diabetes: Implications From in Vitro Studies

Role of T Lymphocytes in Type 2 Diabetes and Diabetes-Associated Inflammation

Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complications

The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications

T-Cell Profile in Adipose Tissue Is Associated With Insulin Resistance and Systemic Inflammation in Humans

The Gut Microbiota Regulates Intestinal CD4 T Cells Expressing RORγt and Controls Metabolic Disease

Elevated Proinflammatory Cytokine Production by a Skewed T Cell Compartment Requires Monocytes and This article is protected by copyright

Promotes Inflammation in Type 2 Diabetes

Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival

IL-17+ CD8+ T cells: Differentiation, phenotype and role in inflammatory disease

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

Impact of Glucose Loading on Variations in CD4+ and CD8+ T Cells in Japanese Participants with or without Type 2 Diabetes

Visceral Adipose Tissue. Arteriosclerosis, Thrombosis, and Vascular Biology

Role of T Cells in Malnutrition and Obesity

Changes in lung morphologic features and elasticity caused by streptozotocin-induced diabetes mellitus in growing This article is protected by copyright. All rights reserved. rats

Cross-Sectional and Prospective Study of Lung Function in Adults With Type 2 Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study

Systematic review of the association between lung function and Type 2 diabetes mellitus

Potential Biochemical Mechanisms of Lung Injury in Diabetes

Respiratory responses of diabetics to hypoxia, hypercapnia, and exercise

A new coronavirus associated with human respiratory disease in China

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

A Novel Angiotensin-Converting Enzyme&#x2013;Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9

Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents

Angiotensin-I-converting enzyme and its relatives

The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections

Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse

Targeting the Adipose Tissue in COVID-19

The relationship between urinary reninangiotensin system markers, renal function, and blood pressure in adolescents with type 1 diabetes. American journal of physiology Renal physiology

Increased urinary angiotensin converting enzyme 2 and neprilysin in patients with type 2 diabetes

Urinary angiotensin converting enzyme 2 increases in patients with type 2 diabetic mellitus. Kidney & blood pressure research

The vasoprotective axes of the renin-angiotensin system: This article is protected by copyright

Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases

Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury

Diabetes and COVID-19: evidence, current status and unanswered research questions

Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility

Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality

Prevalence and impact of diabetes among people infected with SARS-CoV-2

Diabetes patients with COVID-19 need better blood glucose management in Wuhan

The Clinical Characteristics and Outcomes of Diabetes Mellitus and Secondary Hyperglycaemia Patients with Coronavirus Disease

Management of Critically Ill Adults With COVID-19

Viruses and diabetes

Transient diabetes following chicken pox

Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes

Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes

Pancreatic injury patterns in patients with COVID-19 pneumonia

ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Expert recommendation on blood glucose management strategies for diabetes mellitus with new coronavirus pneumonia

Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2

Angiotensin-converting enzyme 2 protects from severe acute lung failure

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV. Zhonghua xin xue guan bing za zhi

Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Development Research

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory medicine

European Society of Cardiology. Position statement of the ESC Council on

Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes & metabolic syndrome

SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission

Impact of Obesity in Patients Infected With 2009 Influenza A(H1N1)

A Novel Risk Factor for a Novel Virus: Obesity and 2009 Pandemic Influenza A (H1N1)

Obesity-related immunodeficiency in patients with pandemic influenza H1N1

Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave

Body mass index and infectious disease mortality in midlife in a cohort of 2.3 million adolescents

Presenting Characteristics, This article is protected by copyright. All rights reserved

Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. Jama. 2020. 111. WHO. Global Health Obsevatory (GHO) data: overweight and obesity

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020. 113. ICNARC report on COVID-19 in critical care

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

Obesity Is a Risk Factor for Greater

Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes

Inflammation and metabolic disorders

Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation and Cytokine Amplification in COVID-19

Monocyte chemoattractant protein 1 in obesity and insulin resistance

Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes

Aging, Obesity, and Inflammatory Age-Related Diseases

Adenovirus 36 as an Obesity Agent Maintains the Obesity State by Increasing MCP-1 and Inducing Inflammation

Human Adenovirus 36 Induces Adiposity, Increases Insulin Sensitivity, and Alters Hypothalamic Monoamines in Rats

ACE2/Ang 1-7 axis: A critical regulator of epicardial adipose tissue inflammation and cardiac dysfunction in obesity

Obesity and This article is protected by copyright

SARS-CoV-2: a population to safeguard. Diabetes/metabolism research and reviews

Influence of Obesity on Pneumococcus Infection Risk in the Elderly

The effect of lipopolysaccharide-induced obesity and its chronic inflammation on influenza virus-related pathology

Diet-induced obesity reduces the production of influenza vaccine-induced antibodies via impaired macrophage function

Impairment of Dendritic Cell Functionality and Steady-State Number in Obese Mice

SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects. Diabetes & metabolic syndrome

Obesity and immune function relationships

The weight of leptin in immunity

Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice

A role for leptin and its cognate receptor in hematopoiesis

Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming

Mechanisms of Leptin Action and Leptin Resistance

Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency

Adiponectin as an anti-inflammatory factor

Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality

Alterations in T-Cell Subset Frequency in Peripheral Blood in Obesity

Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 Influenza a virus

Obesity-Induced Changes in T-Cell Metabolism Are Associated With Impaired Memory T-Cell Response to Influenza and Are Not Reversed With Weight Loss

Obesity impairs γδ T cell homeostasis and antiviral function in humans

Diet-Induced Obesity in Mice Reduces the Maintenance of Influenza-Specific CD8+ Memory T Cells

Obesity Expands a Distinct Population of T Cells in Adipose Tissue and Increases Vulnerability to Infection

B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory This article is protected by copyright. All rights reserved. cytokine profile

Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. mBio

Association of serum complement C3 with metabolic syndrome components in normal weight obese women

Pulmonary system and obesity

Obesity alters the topographical distribution of ventilation and the regional response to bronchoconstriction

Excess Deaths Associated With Underweight, Overweight, and Obesity

Obesity is strongly and independently associated with a higher prevalence of pulmonary embolism. Respiratory investigation

Role of adipose tissue renin-angiotensin This article is protected by copyright. All rights reserved. system in metabolic and inflammatory diseases associated with obesity

Inflammation-Sensitive Plasma Proteins Are Associated With Future Weight Gain

ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet. American journal of physiology Regulatory, integrative and comparative physiology

Obesity and malnutrition similarly alter the renin-angiotensin system and inflammation in mice and human adipose

Obesity-Related Microenvironment Promotes Emergence of Virulent Influenza Virus Strains

Quasispecies theory and the behavior of RNA viruses

Obesity Increases the Duration of Influenza A Virus Shedding in Adults

Biological This article is protected by copyright. All rights reserved

The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study

Adiposity and mortality in older Chinese: an 11-year follow-up of the Guangzhou Biobank Cohort Study

Adiposity and incident diabetes within 4 years of followup: the Guangzhou Biobank Cohort Study. Diabetic medicine : a journal of the British Diabetic Association

Obesity could shift severe COVID-19 disease to younger ages

Increased adiposity in animals due to a human virus

Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids

Adipogenic human adenovirus-36 reduces leptin This article is protected by copyright. All rights reserved. expression and secretion and increases glucose uptake by fat cells

Virus-Induced Interferon-γ Causes Insulin Resistance in Skeletal Muscle and Derails Glycemic Control in

Metabolic effects of influenza virus infection in cultured animal cells: Intra-and extracellular metabolite profiling

The role of macrophages in obesity-associated islet inflammation and β-cell abnormalities

A first Case of Meningitis/Encephalitis associated with SARS-Coronavirus-2

Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory medicine

The relationship among food addiction, negative mood, and eating-disordered behaviors in patients seeking to have bariatric surgery. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non-obese volunteers

Oseltamivir and Oseltamivir Carboxylate Pharmacokinetics in Obese Adults: Dose Modification for Weight Is Not Necessary

Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic

Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic

Regular Exercise Enhances the Immune Response Against Microbial Antigens Through Up-Regulation of Toll-like Receptor Signaling Pathways

Exercise against SARS-CoV-2 (COVID-19): Does workout intensity matter? (A mini review of some indirect evidence related to obesity). Obesity medicine

Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism

Effect of chloroquine on some clinical and biochemical parameters in non-response chronic hepatitis C virus infection patients: pilot clinical trial

Farnesyltransferase inhibitors prevent HIV protease inhibitor (lopinavir/ritonavir)-induced lipodystrophy and metabolic syndrome in mice. Experimental and therapeutic medicine

Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice

Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING. Biochemical and biophysical research communications

Long term azithromycin This article is protected by copyright. All rights reserved. therapy in patients with cystic fibrosis. The Turkish journal of pediatrics

A systematic review of the effect of oral glucocorticoids on energy intake, appetite, and body weight in humans

):e0170259. This article is protected by copyright. All rights reserved. References Infectious disease reviewed Glucose dysregulation Established 24

Influenza, CMV infection

Abbreviation: ATP, adenosine triphosphate

CMV, cytomegalovirus; COVID-19: coronavirus disease

NF-κB: nuclear transcription factor kappa B; PDC, pyruvate dehydrogenase complex

SARS, severe acute respiratory syndrome

 Table 2 . Impact of COVID-19 on diabetes and obesity based on various studies.

Evidence

This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.